Imagine being a doctor who needs to decide how to check for genetic heart risks. In this study, 24 leading experts from the DCM Consortium weighed in on different ways to offer genetic testing for dilated cardiomyopathy. They compared standard in-person visits against models where a doctor or advanced practice provider handled the test remotely or directly. The experts strongly preferred the traditional, in-person approach over the other options.
When it came to using genetic results for major decisions like implanting a device or considering a transplant, most experts said yes to using that information. Yet, the study highlights a big problem: care for this condition varies wildly across different hospital sites. There is no single, defined way to do this genetic evaluation yet.
This research does not prove that one method is better for patients, but it shows that doctors feel more comfortable with traditional visits. Because the study only asked 24 experts, we cannot yet say what will work for everyone. Understanding these differences is the first step toward creating care plans that are easier to copy and use everywhere.